CVRx, Inc.
NASDAQ: CVRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin Hykes
- Employees
- 206
- Headquarters
- Minneapolis, United States
- IPO year
- 2021
- Market cap
- $136.8M
- Website
- https://www.cvrx.com
Loading CVRX…
Loading profile data…Frequently asked questions about CVRX
What does CVRx, Inc. (CVRX) do?
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with...
Where does CVRX trade?
CVRx, Inc. (CVRX) trades on the NASDAQ Global Select.
What sector is CVRX in?
CVRx, Inc. (CVRX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of CVRx, Inc.?
Kevin Hykes is the chief executive officer of CVRx, Inc. (CVRX).
Where is CVRx, Inc. headquartered?
CVRx, Inc. is headquartered in United States.
Does CVRX pay a dividend?
CVRx, Inc. (CVRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CVRX go public?
CVRx, Inc. (CVRX) completed its initial public offering in 2021.